MAP2 immunoreactivity deficit is conserved across the cerebral cortex within individuals with schizophrenia
Open Access
- 28 August 2019
- journal article
- research article
- Published by Springer Science and Business Media LLC in Schizophrenia
- Vol. 5 (1), 13
- https://doi.org/10.1038/s41537-019-0081-0
Abstract
Several postmortem studies have reported lower levels of immunoreactivity (IR) for microtubule-associated protein 2 (MAP2) in several cortical regions of individuals with schizophrenia (SZ). However, whether this effect is conserved across multiple brain areas within an individual with SZ or if it is regionally-specific remains unclear. We characterized patterns of MAP2-IR across three cortical regions at different levels of the rostral-caudal axis within individual subjects with and without SZ. MAP2-IR levels were measured in deep layer 3 of dorsolateral prefrontal cortex (DLPFC), lateral intraparietal cortex (LIP), and primary visual cortex (V1). Postmortem tissue containing each cortical region was derived from 20 pairs of SZ subjects and nonpsychiatric comparison (NPC) subjects matched perfectly for sex, and as closely as possible for age and postmortem interval. MAP2-IR was assessed by quantitative fluorescence microscopy. We observed significantly lower levels of MAP2-IR in SZ subjects relative to NPC subjects, without a significant region by diagnosis interaction. Logs of the within-pair ratios (SZ: NPC) of MAP2-IR were significantly correlated across the three regions. These findings demonstrate that MAP2-IR deficits in SZ are consistent across three neocortical regions within individual subjects. This pattern of MAP2-IR deficit has implications for therapeutic development and future investigations of MAP2 pathology in SZ.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (MH071533, MH103204)
This publication has 64 references indexed in Scilit:
- Pyramidal neuron number in layer 3 of primary auditory cortex of subjects with schizophreniaBrain Research, 2009
- Working memory and DLPFC inefficiency in schizophrenia: The FBIRN studySchizophrenia Bulletin, 2008
- Microtubules in Dendritic Spine DevelopmentJournal of Neuroscience, 2008
- Reduced Dendritic Spine Density in Auditory Cortex of Subjects with SchizophreniaNeuropsychopharmacology, 2008
- Increased lactate levels and reduced pH in postmortem brains of schizophrenics: Medication confoundsJournal of Neuroscience Methods, 2008
- Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expressionMolecular Psychiatry, 2008
- Altered proteins of the anterior cingulate cortex white matter proteome in schizophreniaProteomics – Clinical Applications, 2007
- Primary visual cortex volume and total neuron number are reduced in schizophreniaJournal of Comparative Neurology, 2007
- Performance of patients with schizophrenia on a pen and paper visuospatial working memory task with short delaySchizophrenia Research, 1997
- Mitogen‐activated‐protein‐kinase‐catalyzed phosphorylation of microtubule‐associated proteins, microtubule‐associated protein 2 and microtubule‐associated protein 4, induces an alteration in their functionJBIC Journal of Biological Inorganic Chemistry, 1992